BCITX
Price
$11.26
Change
-$0.00 (-0.00%)
Updated
Jun 17 closing price
Net Assets
2.25B
NCMAX
Price
$9.84
Change
-$0.00 (-0.00%)
Updated
Jun 17 closing price
Net Assets
259.36M
Interact to see
Advertisement

BCITX vs NCMAX

BCITX vs NCMAX Comparison Chart in %
View a ticker or compare two or three
VS
BCITX vs. NCMAX commentary
Jun 19, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BCITX is a Hold and NCMAX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
BCITX has more cash in the bank: 2.25B vs. NCMAX (259M). BCITX (3.04) and NCMAX (2.95) have matching dividends . BCITX was incepted earlier than NCMAX: BCITX (43 years) vs NCMAX (24 years). NCMAX (0.58) is less costly to investors than BCITX (0.47). BCITX is a more actively managed with annual turnover of: 61.00 vs. NCMAX (16.00). NCMAX has a lower initial minimum investment than BCITX: NCMAX (2000) vs BCITX (2500). BCITX annual gain was more profitable for investors over the last year : 5.83 vs. NCMAX (5.48). NCMAX (4.86) and BCITX (4.76) have equivalent 5 years return.
BCITXNCMAXBCITX / NCMAX
Total Expense Ratio0.470.4898%
Annual Report Gross Expense Ratio0.470.5881%
Fund Existence43 years24 years-
Gain YTD1.0961.044105%
Front LoadN/AN/A-
Min. Initial Investment25002000125%
Min. Initial Investment IRAN/AN/A-
Net Assets2.25B259M869%
Annual Yield % from dividends3.042.95103%
Returns for 1 year5.835.48106%
Returns for 3 years10.659.96107%
Returns for 5 years4.764.8698%
Returns for 10 years18.5216.38113%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CRVS12.010.27
+2.30%
Corvus Pharmaceuticals
CTVA77.370.50
+0.65%
Corteva
KTTA0.50-0.01
-1.51%
Pasithea Therapeutics Corp
FFIN32.57-0.82
-2.46%
First Financial Bankshares
JFIN3.92-0.15
-3.69%
Jiayin Group